Lung Kee (Bermuda) Changes Name to Lung Kee Group
The Long Kee Bermuda Group (00255) has adopted the Chinese name "Long Kee Group Holding Co., Ltd." as its second name.
Dragon Record Group (00255) announced that after the special resolution to change the company name was passed at the shareholder's annual meeting held on May 27, 2024, the Bermuda company registry issued a certificate of name change and a second name certificate on May 28, 2024, proving that the company's English name has been changed from 'Lung Kee (Bermuda) Holdings Limited' to 'Lung Kee Group Holdings Limited', and adopting the Chinese name '龙记集团控'.
Lung Kee (Bermuda) Shareholders Unite in Approval
LUNG KEE: 2023 ANNUAL REPORT
LUNG KEE To Go Ex-Dividend On May 31st, 2024 With 0.05 HKD Dividend Per Share
Lung Kee Group (00255) plans to change its name to “Lung Kee Group Holdings Limited”
Lung Kee Group (00255) announced that the board of directors recommended changing the company's English name to “Lung Kee (Be...
Lung Kee Group (00255) will pay a final dividend of HK$0.05 per share on June 18
Lung Kee Group (00255) announced that it will distribute on June 18, 2024 until 2024 1...
Lung Kee Group (00255.HK): Loss attributable to company owners HK$72.431 million in 2023
On March 22, Ge Longhui Group (00255.HK) announced that for the year ended December 31, 2023, the Group's revenue was HK$1,449 billion, down 9.5% year on year; loss attributable to company owners was HK$72,431 million, profit in 2022 was HK$158.14 million, and the basic loss per share was HK11.47 cents. A proposed final dividend of HK5 cents per share.
LUNG KEE: FINAL RESULTS FOR THE YEAR ENDED 31ST DECEMBER, 2023
Lung Kee Group (00255.HK) plans to hold a board meeting on March 22 to approve annual results
Glonghui, March 7, 丨 Lung Kee Group (00255.HK) announced that the company will hold a board meeting at 2:00 p.m. on March 22, 2024 (Friday) at 2:00 p.m., in room A, 15th floor, Jingrui Plaza Phase 2, 1 Anqun Street, Shatin, New Territories, Hong Kong to (including) approve the publication of the final results announcement of the company and its subsidiaries for the year ended 31 December 2023 and consider the payment of a final dividend.
Lung Kee (Bermuda) to Delist From Singapore Exchange on Feb. 5
Lung Kee Group (00255.HK): Will be delisted from the SGX Main Board listing list starting February 5
Gelonghui, January 31 | Longji Group (00255.HK) announced that the shares will be delisted from the SGX Main Board listing list, effective at 9:00 a.m. (Singapore time) on the delisting date (i.e. February 5, 2024 (Monday)).
Trading of Lung Kee's Shares to Be Suspended From Singapore Bourse on Jan. 22
Lung Kee (Bermuda) Discloses Trading Suspension on Singapore Exchange
Lung Kee Group (00255.HK): Shares voluntarily delisted on the main board of the SGX
On January 19, Ge Longhui Group (00255.HK) issued an announcement to stop trading shares on the SGX starting January 22, 2024 (Monday) at 9:00 a.m. (Singapore time). Therefore, the last date for shares to be traded on the SGX is January 19, 2024 (Friday).
Lung Kee (Bermuda) Flags Losses for 2023
Lung Kee Group (00255.HK) Profit Alert: Expected annual net loss of not less than HK$70 million
On January 5, Ge Longhui Group (00255.HK) announced that compared with the net profit of HK$16 million for the year ended 31 December 2022, the Group is expected to record a net loss of no less than HK$70 million for the year ended 31 December 2023. The main reason for the expected change in the Group's performance from profit to loss is that the Group's sales revenue continues to be at a low level due to the poor economic environment, and the inevitable reduction in sales prices due to the difficult operating environment.
Lung Kee to Delist From Singapore Bourse in February 2024
Lung Kee Group (00255.HK) granted 2.43 million share options
Glonghui, September 28, 丨 Longji Group (00255.HK) announced that according to the share option plan adopted on May 30, 2022, the company granted 2.43 million additional rights to certain grantees to subscribe for a total of 2.43 million shares of the company's share capital with a face value of HK$0.10 per share, but only after acceptance by the grantor.
Lung Kee to Delist Shares Traded on Singapore Bourse
No Data